Evidence map›Paper›PMID 39943238›Full record

ArticleSensors (Basel, Switzerland)2025

The Development and Optimisation of a Urinary Volatile Organic Compound Analytical Platform Using Gas Sensor Arrays for the Detection of Colorectal Cancer.

Ramesh P Arasaradnam, Ashwin Krishnamoorthy, Mark A Hull, Peter Wheatstone, Frank Kvasnik, Krishna C Persaud

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramesh P ArasaradnamInstitute of Precision Diagnostics & Translational Medicine, University Hospitals Coventry & Warwickshire, Coventry CV2 2DX, UK.ORCID 0000-0002-2231-3062
Ashwin KrishnamoorthyInstitute of Precision Diagnostics & Translational Medicine, University Hospitals Coventry & Warwickshire, Coventry CV2 2DX, UK.ORCID 0000-0003-2480-8664
Mark A HullLeeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK.ORCID 0000-0001-7414-1576
Peter WheatstoneLeeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK.ORCID 0000-0003-0869-3449
Frank KvasnikDepartment of Chemical Engineering, The University of Manchester, Manchester M13 9PL, UK.
Krishna C PersaudDepartment of Chemical Engineering, The University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-5730-9568

Funding

National Institute for Health Research 127800The Bardhan Research & Education Trust 0690
6 · The paper itself

Abstract

The profile of Volatile Organic Compounds (VOCs) may help prioritise at-risk groups for early cancer detection. Urine sampling has been shown to provide good disease accuracy whilst being patient acceptable compared to faecal analysis. Thus, in this study, urine samples were examined using an electronic nose with metal oxide gas sensors and a solid-phase microextraction sampling system. A calibration dataset (derived from a previous study) with CRC-positive patients and healthy controls was used to train a radial basis function neural network. However, a blinded analysis failed to detect CRC accurately, necessitating an enhanced data-processing strategy. This new approach categorised samples by significant bowel diseases, including CRC and high-risk polyps. Retraining the neural network showed an area under the ROC curve of 0.88 for distinguishing CRC versus non-significant bowel disease (without CRC, polyps or inflammation). These findings suggest that, with appropriate training sets, urine VOC analysis could be a rapid, low-cost method for early detection of precancerous colorectal polyps and CRC.

Indexed as

Colorectal NeoplasmsVolatile Organic CompoundsAgedElectronic NoseFemaleGasesHumansMaleMiddle AgedNeural Networks, ComputerSolid Phase MicroextractionGasesVolatile Organic Compoundsanalytical platform developmentcolorectal cancer detectionnon-invasive screeningradial basis function neural networksignificant bowel diseasesolid-phase microextractionurinary volatile organic compounds

Identifiers

PMID39943238
PMCPMC11820771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.